ArticleCell death discovery2018

A two-microRNA-based signature predicts first-line chemotherapy outcomes in advanced colorectal cancer patients.

Jia-Huan Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.